A study published in The ISME Journal in 2026 offers a new explanation for how vitamin B12 circulates within the gut microbiome: bacteriophages, the viruses that infect bacteria, may be doing much of the distribution work by bursting open the cells that make it.
What the study found
Vitamin B12 (cobalamin, part of the broader cobamide family of compounds) is made by only a subset of bacteria, yet many other microbes — and the human host — depend on it. Researchers led by Bryan B. Hsu at Virginia Tech’s Department of Biological Sciences, with first author David da Silva Barreira, set out to test how B12 actually gets from producer cells to the wider community when it is normally held inside the cell rather than secreted.
Using genetically well-defined co-culture systems, the team showed that when a bacteriophage infects and lyses a B12-producing bacterium, it releases B12 at concentrations high enough to support the growth of B12-dependent bacteria growing alongside it. Producer strains engineered to lack B12 production, and cultures without phage present, did not support that growth — indicating the vitamin was not simply leaking out on its own. The team then validated the effect using major taxa from the human gut, and found that phage-mediated lysis measurably altered the composition and diversity of mixed bacterial communities in a B12-dependent way; supplementing B12 directly muted much of that effect, reinforcing that phage-driven release, not just B12’s presence, was doing the work.
“In a genetically well-defined system, we can demonstrate that phage is necessary,” Hsu said. “The B12 doesn’t just leak out.”
Why this matters beyond one nutrient
The finding reframes phage predation as more than a population-control mechanism within a phage’s direct host range. By rupturing producer cells, phages appear to act as a nutrient-recycling mechanism that can modulate community composition well beyond the specific bacteria they infect — any organism dependent on the released cobamide stands to benefit or be disadvantaged by the timing and scale of lysis events. For a microbiome field that has spent the past decade mapping who is present, this points toward mechanisms that govern who can actually persist and grow, tying phage ecology directly to host-relevant micronutrient availability.
Funding and data availability
The work was supported by the National Institute of General Medical Sciences at the US National Institutes of Health (award R35GM147484 to Hsu). Consistent with standard practice for microbiome research, the underlying 16S rRNA amplicon sequencing data was deposited in a public NCBI BioProject record, and the figure-generating datasets were placed in a Zenodo repository under an assigned DOI — the kind of data availability statement and public deposition that funders increasingly expect and that downstream researchers rely on to reanalyze or extend a dataset without repeating the wet-lab work.
Why research administrators should note this
Beyond the microbiology, the study is a compact example of the data-stewardship expectations now standard for NIH-funded molecular biology: a named funding mechanism, a public sequence-data accession, and an openly deposited analysis archive, all disclosed alongside the paper itself. That combination is what makes findings like this independently checkable and reusable rather than simply cited — a distinction increasingly relevant as funders and journals formalize expectations around FAIR data principles and rigor and reproducibility in funded research (see NIH’s own rigor and reproducibility policy). Research administrators supporting microbiome, genomics, or other high-throughput biology labs will recognize the pattern: a BioProject accession and a Zenodo DOI sitting quietly in the methods section, doing the unglamorous work of making the science auditable.
